Shensong Yangxin Protects Against Metabolic Syndrome-Induced Ventricular Arrhythmias by Inhibiting Electrical Remodeling
Shensong Yangxin (SSYX) is a traditional Chinese medicine, which has been proven to improve the clinical symptoms of arrhythmia. However, the role of SSYX in metabolic syndrome (MetS)-induced electrical remodeling remains to be fully elucidated. Here, we sought to clarify whether SSYX can alter the...
Main Authors: | Hong-Jie Yang, Bin Kong, Wei Shuai, Jing-jing Zhang, He Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00993/full |
Similar Items
-
Effect of Shensong Yangxin capsule in combined with metroprolol succinate on the hemodynamics and heart rate variability in patients with arrhythmia of coronary heart disease
by: Ai-Ru Xu, et al.
Published: (2018-03-01) -
Clinical Efficacy and Safety of Shensong Yangxin Capsule-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Meta-Analysis of Randomized Controlled Trials
by: Xinfu Cao, et al.
Published: (2021-02-01) -
Effect of Shensong Yangxin on the Progression of Paroxysmal Atrial Fibrillation is Correlated with Regulation of Autonomic Nerve Activity
by: Hong-Yi Zhao, et al.
Published: (2017-01-01) -
Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial
by: Xi Wang, et al.
Published: (2017-01-01) -
Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure
by: Ma J, et al.
Published: (2018-10-01)